144 related articles for article (PubMed ID: 37390110)
1. In-vitro high-throughput library screening-Kinetics and molecular docking studies of potent inhibitors of α-glucosidase.
Ali M; Malik K; Zaidi A; Farooq U; Bukhari SM; Majeed Z; Mahnashi MH; Nawazish S; Abdulwahab A; Alshaibari KS
PLoS One; 2023; 18(6):e0286159. PubMed ID: 37390110
[TBL] [Abstract][Full Text] [Related]
2. Study on the Interaction of 1,5-diaryl Pyrrole Derivatives with α- glucosidase; Synthesis, Molecular Docking, and Kinetic Study.
Tafesse TB; Moghadam ES; Bule MH; Faramarzi MA; Abdollahi M; Amini M
Med Chem; 2021; 17(5):545-553. PubMed ID: 31808390
[TBL] [Abstract][Full Text] [Related]
3. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship,
Mughal EU; Amjid S; Sadiq A; Naeem N; Nazir Y; Alrafai HA; Hassan AA; Al-Nami SY; Abdel Hafez AA; Ali Shah SW; Ghias M
J Biomol Struct Dyn; 2024; 42(1):244-260. PubMed ID: 37096830
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.
Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM
Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.
Ritu ; Sharma P; Gupta GD; Asati V
Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530
[TBL] [Abstract][Full Text] [Related]
8. Utilization of the common functional groups in bioactive molecules: Exploring dual inhibitory potential and computational analysis of keto esters against α-glucosidase and carbonic anhydrase-II enzymes.
Khan I; Khan A; Halim SA; Khan M; Zaib S; Al-Yahyaei BEM; Al-Harrasi A; Ibrar A
Int J Biol Macromol; 2021 Jan; 167():233-244. PubMed ID: 33249154
[TBL] [Abstract][Full Text] [Related]
9. Triterpenic Acids as Non-Competitive α-Glucosidase Inhibitors from
Ur Rehman N; Halim SA; Al-Azri M; Khan M; Khan A; Rafiq K; Al-Rawahi A; Csuk R; Al-Harrasi A
Biomolecules; 2020 May; 10(5):. PubMed ID: 32408614
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, α-Amylase/α-Glucosidase Inhibition Assay, Induced Fit Docking Study of New Hybrid Compounds Containing 4H-Pyrano[2,3-d]pyrimidine, 1H-1,2,3-Triazole and D-Glucose Components.
Toan VN; Thanh ND; Huyen LT; Hanh NT; Hai DS; Anh HH; Giang NTK; Van HTK
Chem Biodivers; 2022 Dec; 19(12):e202200680. PubMed ID: 36408921
[TBL] [Abstract][Full Text] [Related]
11.
Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
[TBL] [Abstract][Full Text] [Related]
12. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
13. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro inhibitor screening, structure-activity relationship, and molecular dynamic simulation studies of novel thioquinoline derivatives as potent α-glucosidase inhibitors.
Forozan R; Ghomi MK; Iraji A; Montazer MN; Noori M; Dastyafteh N; Mojtabavi S; Faramarzi MA; Sadat-Ebrahimi SE; Larijani B; Javanshir S; Mahdavi M
Sci Rep; 2023 May; 13(1):7819. PubMed ID: 37188744
[TBL] [Abstract][Full Text] [Related]
15. Synthesis,
Lin P; Zeng JC; Chen JG; Nie XL; Yuan E; Wang XQ; Peng DY; Yin ZP
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1879-1890. PubMed ID: 33003963
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation, and docking study of new triazole-phenylacetamide derivatives as α-glucosidase inhibitors.
Luo S; Yang W; Huang Y; Peng Z; Wang G
Bioorg Chem; 2023 Dec; 141():106844. PubMed ID: 37703743
[TBL] [Abstract][Full Text] [Related]
17. One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors.
Karami M; Hasaninejad A; Mahdavi H; Iraji A; Mojtabavi S; Faramarzi MA; Mahdavi M
Mol Divers; 2022 Oct; 26(5):2393-2405. PubMed ID: 34697701
[TBL] [Abstract][Full Text] [Related]
18. Flavone-1,2,3-triazole derivatives as potential α-glucosidase inhibitors: Synthesis, enzyme inhibition, kinetic analysis and molecular docking study.
Dhameja M; Kumar H; Kurella S; Uma A; Gupta P
Bioorg Chem; 2022 Oct; 127():106028. PubMed ID: 35868105
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Insights into the Inhibitory Activities of Chemical Constituents from the Fruits of Terminalia boivinii on α-Glucosidase.
Dlamini BS; Chen CR; Chen YK; Hsu JL; Shih WL; Chang CI
Chem Biodivers; 2022 Jul; 19(7):e202200137. PubMed ID: 35726787
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Sharafi Z; Faramarzi MA; Rastegar H; Nasli Esfahani E; Bandarian F; Ranjbar Rashidi P; Rahimi R; Biglar M; Mahdavi M; Larijani B
Mol Divers; 2021 May; 25(2):877-888. PubMed ID: 32189236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
